☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
BMS Reports P-III (COMMANDS) Study Results of Reblozyl (luspatercept-aamt) for Myelodysplastic Syndromes
October 31, 2022
Natalie Shiff, Associate Medical Director, Janssen Rheumatology Shares Insights from the FDA Approval of Stelara to Treat Pediatri...
October 31, 2022
Innovent Reports First Patient Dosing of IBI343 in P-I Study for the Treatment of Advanced Solid Tumors
October 31, 2022
Outlook Therapeutics Reports the US FDA Acceptance of BLA for ONS-5010 to Treat Wet AMD
October 31, 2022
CytoDyn Reports the Withdrawal of BLA for Leronlimab to Treat HIV
October 31, 2022
AbbVie Reports EMA's Validation of MAA for Epcoritamab to Treat Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Large B-Cell...
October 31, 2022
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions